Polaryx Therapeutics (PLYX) Other Accumulated Expenses (2024 - 2026)

Polaryx Therapeutics (PLYX) has reported Other Accumulated Expenses for 3 consecutive years, with $98000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $98000.0; the TTM figure through Mar 2026 stood at $98000.0 (changed N/A YoY), while the FY2025 annual figure was $91000.0, down 30.0% from the prior year.
• Other Accumulated Expenses grew to $98000.0 in Q1 2026 per PLYX's latest filing, from $91000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $130000.0 in Q4 2024 and bottomed at $91000.0 in Q4 2025.
• Historically, Other Accumulated Expenses has averaged $106333.3 across 3 years, with a median of $98000.0 in 2026.
• On a YoY basis, Other Accumulated Expenses climbed as much as 30.0% in 2025 and fell as far as 30.0% in 2025.
• Polaryx Therapeutics' Other Accumulated Expenses stood at $130000.0 in 2024, then fell by 30.0% to $91000.0 in 2025, then rose by 7.69% to $98000.0 in 2026.
• Business Quant data shows PLYX's Other Accumulated Expenses at $98000.0 in Q1 2026, $91000.0 in Q4 2025, and $130000.0 in Q4 2024.